Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

gan Mouriaux, F, Servois, V, Parienti, J J, Lesimple, T, Thyss, A, Dutriaux, C, Neidhart-Berard, E M, Penel, N, Delcambre, C, Peyro Saint Paul, L, Pham, A D, Heutte, N, Piperno-Neumann, S, Joly, F
Cyhoeddwyd yn Br J Cancer (2016)